Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

University of California, Los Angeles · RTOG Foundation · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

920
total citations
FWCI
48.97
Percentile
100%
References
20
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Goserelin
  • Prostatectomy
  • Urology
  • Radiation therapy
  • Androgen suppression
  • Prostate
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.